Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - NET CHANGE IN CASH
Net Change in Cash ALNY - Alnylam Pharmaceuticals, Inc.
-53.7 M
LAST VALUE
-7.99%
2 YEAR CAGR
24.87%
5 YEAR CAGR
-41.17%
10 YEAR CAGR